Pentagon Awards $64.6 Million Contract to SiO2 Medical Products to Increase Domestic Production Capacity of Pharmaceutical Vials

U.S. Department of Defense

On July 26, 2021, the Department of Defense (DOD), on behalf of and in coordination with the Department of Health and Human Services (HHS), awarded a $64.6 million contract modification to SiO2 Medical Products to increase domestic production of pharmaceutical vials made of hybrid, glass-equivalent materials.

This domestic industrial base expansion effort will allow SiO2 to design, develop, and build a series of three vial production systems in Auburn, Alabama.

This effort will increase vial production to 10 million vials per month by July 2024.

/Public Release. This material comes from the originating organization/author(s)and may be of a point-in-time nature, edited for clarity, style and length. The views and opinions expressed are those of the author(s).View in full here.